Summit Trail Advisors LLC Purchases 349 Shares of KKR & Co. Inc. (NYSE:KKR)

Summit Trail Advisors LLC grew its position in shares of KKR & Co. Inc. (NYSE:KKR) by 9.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,955 shares of the asset manager’s stock after buying an additional 349 shares during the period. Summit Trail Advisors LLC’s holdings in KKR & Co. Inc. were worth $517,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Larson Financial Group LLC increased its holdings in shares of KKR & Co. Inc. by 2.8% during the third quarter. Larson Financial Group LLC now owns 33,272 shares of the asset manager’s stock valued at $4,345,000 after acquiring an additional 920 shares in the last quarter. MGB Wealth Management LLC increased its holdings in shares of KKR & Co. Inc. by 10.8% during the third quarter. MGB Wealth Management LLC now owns 5,150 shares of the asset manager’s stock valued at $672,000 after acquiring an additional 500 shares in the last quarter. Swedbank AB increased its holdings in shares of KKR & Co. Inc. by 10.6% during the third quarter. Swedbank AB now owns 72,374 shares of the asset manager’s stock valued at $9,451,000 after acquiring an additional 6,942 shares in the last quarter. Okabena Investment Services Inc. boosted its position in shares of KKR & Co. Inc. by 6.5% during the third quarter. Okabena Investment Services Inc. now owns 5,168 shares of the asset manager’s stock valued at $675,000 after buying an additional 314 shares during the last quarter. Finally, Pitcairn Co. purchased a new position in shares of KKR & Co. Inc. during the third quarter valued at approximately $216,000. Institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Stock Up 1.5 %

KKR stock opened at $161.27 on Wednesday. The stock has a market cap of $143.24 billion, a P/E ratio of 49.02, a P/E/G ratio of 1.26 and a beta of 1.61. The stock’s fifty day simple moving average is $140.99 and its two-hundred day simple moving average is $122.33. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.82. KKR & Co. Inc. has a 1-year low of $68.58 and a 1-year high of $161.53.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Thursday, October 24th. The asset manager reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.35. The firm had revenue of $4.79 billion for the quarter, compared to analyst estimates of $1.23 billion. KKR & Co. Inc. had a return on equity of 5.77% and a net margin of 13.21%. During the same period in the previous year, the company posted $0.73 earnings per share. Analysts expect that KKR & Co. Inc. will post 4.16 EPS for the current year.

KKR & Co. Inc. Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th were paid a $0.175 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.70 annualized dividend and a dividend yield of 0.43%. KKR & Co. Inc.’s payout ratio is presently 21.28%.

Insider Buying and Selling at KKR & Co. Inc.

In related news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the purchase, the insider now owns 92,959,984 shares in the company, valued at $1,034,644,621.92. This trade represents a 14.29 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The trade was a 18.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 39.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Wells Fargo & Company lifted their target price on KKR & Co. Inc. from $139.00 to $152.00 and gave the company an “equal weight” rating in a research report on Friday, October 25th. Evercore ISI lifted their target price on KKR & Co. Inc. from $135.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Morgan Stanley lifted their target price on KKR & Co. Inc. from $107.00 to $143.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Hsbc Global Res raised KKR & Co. Inc. to a “strong-buy” rating in a research report on Wednesday, September 18th. Finally, HSBC assumed coverage on KKR & Co. Inc. in a research report on Wednesday, September 18th. They set a “buy” rating and a $148.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, KKR & Co. Inc. currently has a consensus rating of “Moderate Buy” and a consensus price target of $154.14.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.